Publicaciones
El conocimiento generado en IrsiCaixa se comparte con la comunidad científica a través de la publicación de artículos en revistas científicas de alto impacto.
Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents.
Long-term HIV-1 infection induces an antiviral state in primary macrophages.
Inhibition of herpes simplex virus type 1 by the CDK6 inhibitor PD-0332991 (palbociclib) through the control of SAMHD1.
Design, synthesis and biological evaluation of pyrido[2,3-d]pyrimidin-7-(8H)-ones as HCV inhibitors.
SAMHD1: at the crossroads of cell proliferation, immune responses, and virus restriction.
Cyclin D3-dependent control of the dNTP pool and HIV-1 replication in human macrophages.
The thioacetate-ω(γ-lactam carboxamide) HDAC inhibitor ST7612AA1 as HIV-1 latency reactivation agent.
BMS-663068, a safe and effective HIV-1 attachment inhibitor.
Cell cycle control and HIV-1 susceptibility are linked by CDK6-dependent CDK2 phosphorylation of SAMHD1 in myeloid and lymphoid cells.
New indolylarylsulfones as highly potent and broad spectrum HIV-1 non-nucleoside reverse transcriptase inhibitors.